Microglial Piezo1 senses Aβ fibril stiffness to restrict Alzheimer's disease

Neuron. 2023 Jan 4;111(1):15-29.e8. doi: 10.1016/j.neuron.2022.10.021. Epub 2022 Nov 10.

Abstract

The pathology of Alzheimer's disease (AD) is featured with extracellular amyloid-β (Aβ) plaques, whose impact on the mechanical properties of the surrounding brain tissues is unclear. Microglia sense and integrate biochemical cues of the microenvironment. However, whether the microglial mechanosensing pathways influence AD pathogenesis is unknown. Here, we surveyed the elevated stiffness of Aβ-plaque-associated tissues and observed the selective upregulation of the mechanosensitive ion channel Piezo1 in Aβ-plaque-associated microglia. Piezo1 sensed the stiffness stimuli of Aβ fibrils and subsequently induced Ca2+ influx for microglial clustering, phagocytosis, and compacting of Aβ plaques. Microglia lacking Piezo1 led to the exacerbation of Aβ pathology and cognitive decline, whereas pharmacological activation of microglial Piezo1 ameliorated brain Aβ burden and cognitive impairment in 5 × FAD mice. Together, our results reveal that Piezo1, a mechanosensor of Aβ fibril stiffness in microglia, represents a potential therapeutic target for AD.

Keywords: Alzheimer’s disease; Aβ plaque; Piezo1; microglial mechanosensor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / metabolism
  • Amyloid / metabolism
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Disease Models, Animal
  • Ion Channels / metabolism
  • Mice
  • Mice, Transgenic
  • Microglia / metabolism
  • Plaque, Amyloid / metabolism

Substances

  • Amyloid beta-Peptides
  • Amyloid
  • Piezo1 protein, mouse
  • Ion Channels